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Abstract
Background: Low back pain (LBP) is a prevalent and costly condition in the United States. Evidence suggests there
is no one treatment which is best for all patients, but instead several viable treatment options. Additionally,
multidisciplinary management of LBP may be more effective than monodisciplinary care. An integrative model that
includes both complementary and alternative medicine (CAM) and conventional therapies, while also incorporating
patient choice, has yet to be tested for chronic LBP.
The primary aim of this study is to determine the relative clinical effectiveness of 1) monodisciplinary chiropractic
care and 2) multidisciplinary integrative care in 200 adults with non-acute LBP, in both the short-term (after 12
weeks) and long-term (after 52 weeks). The primary outcome measure is patient-rated back pain. Secondary aims
compare the treatment approaches in terms of frequency of symptoms, low back disability, fear avoidance, self-effi-
cacy, general health status, improvement, satisfaction, work loss, medication use, lumbar dynamic motion, and
torso muscle endurance. Patients’ and providers’ perceptions of treatment will be described using qualitative meth-
ods, and cost-effectiveness and cost utility will be assessed.
Methods and Design: This paper describes the design of a randomized clinical trial (RCT), with cost-effectiveness
and qualitative studies conducted alongside the RCT. Two hundred participants ages 18 and older are being
recruited and randomized to one of two 12-week treatment interventions. Patient-rated outcome measures are
collected via self-report questionnaires at baseline, and at 4, 12, 26, and 52 weeks post-randomization. Objective
outcome measures are assessed at baseline and 12 weeks by examiners blinded to treatment assignment. Health
care cost data is collected by self-report questionnaires and treatment records during the intervention phase and
by monthly phone interviews thereafter. Qualitative interviews, using a semi-structured format, are conducted with
patients at the end of the 12-week treatment period and also with providers at the end of the trial.
Discussion: This mixed-methods randomized clinical trial assesses clinical effectiveness, cost-effectiveness, and
patients’ and providers’ perceptions of care, in treating non-acute LBP through evidence-based individualized care
delivered by monodisciplinary or multidisciplinary care teams.
Trial registration: ClinicalTrials.gov NCT00567333
Background
It is well recognized that low back pain (LBP) is one of
the most prevalent and costly problems facing the US
health-care system [1-3]. Approximately 80% of indivi-
duals will experience non-specific LBP in their lifetime[4]
and 75% will experience lingering problems one year
after onset[5]. In the United Kingdom, the incidence of
chronic low back disability rose exponentially for two
decades through 1994,[6] and for some patients the asso-
ciated psychological distress and illness behaviors
become as disabling as the LBP itself[7]. In the United
States, the costs attributable to LBP continue to soar and
are estimated to exceed $100 billion dollars annually[8].
At present, more than 500 randomized controlled
trials have been published evaluating conservative and
alternative treatments for LBP. From the results of these
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cific LBP that is best for all patients, but instead, several
viable treatment options [9-12].
Although LBP is common, each patient and their low
back pain experience is unique. Using biopsychosocial
measures to individualize treatment may be more appro-
priate than a “one size fits all” approach. Having multiple
efficacious treatments also introduces greater opportu-
nity for choice, which, by allowing expression of patient
preference, may positively affect treatment outcomes[13].
Additionally, by combining the efforts and care of multi-
ple providers, it is hypothesized that a collective approach
can exceed what can be accomplished by monodisciplin-
ary care, particularly for chronic conditions [14-18].
T h e r ei se v i d e n c ef r o ma tl e a s to n eR C T [ 1 9 ]t os u g -
gest that providing individualized treatment within a
multidisciplinary, conventional medicine care pathway
results in faster return to work for chronic LBP patients.
Integrative care, including both CAM and conventional
therapies for chronic LBP, is an approach with the
potential to improve upon the fragmented and extre-
mely costly delivery system currently in place and is
worthy of further rigorous exploration.
This paper describes the protocol of a mixed-methods
randomized clinical trial designed to compare monodisci-
plinary, chiropractic care with multidisciplinary, integra-
tive care for chronic LBP. Both the monodisciplinary and
multidisciplinary care are delivered within the context of
individualized, evidence-based clinical care pathways.
Primary Aim
The primary aim of the study is to determine the rela-
tive clinical efficacy of 1) monodisciplinary, chiroprac-
tic care and 2) multidisciplinary, integrative care for
LBP of greater than 6 weeks duration, in both the short-
term (after 12 weeks) and long-term (after 52 weeks).
Patient-rated back pain is the primary outcome measure.
Secondary Aims
T h es e c o n d a r ya i m so ft h es t u d ya r et od e t e r m i n et h e
short- and long-term relative efficacy of the two inter-
ventions using the following secondary patient-rated
outcome measures: frequency of symptoms, low back
disability, fear avoidance, self-efficacy, general health sta-
tus, improvement, satisfaction, work loss, and medica-
tion use.
We will also determine the relative efficacy of the two
interventions in terms of objective outcomes, lumbar
dynamic motion and torso muscle endurance, measured
by examiners blinded to treatment group assignment.
Methods and Design
This study is being conducted at the Wolfe-Harris Cen-
ter for Clinical Studies at Northwestern Health Sciences
University (NWHSU) in Minneapolis, Minnesota.
Recruitment began in April 2007 and is now complete.
Approval was granted by the Institutional Review Boards
of NWHSU and the Minneapolis Medical Research
Foundation. Written informed consent was obtained
from all participants.
Study population
Two hundred participants were recruited from the Twin
Cities metropolitan area through targeted postcard mail-
ings, brochures at community events, advertisements in
online local newspapers, and links on the University’s
website.
Inclusion Criteria
Individuals must be 18 years or older with a current epi-
sode of LBP at least 6 weeks in duration. Participants’
low back complaint must meet the Quebec Task Force
classifications of 1, 2, 3, or 4 (individuals with back pain,
stiffness, or tenderness with or without musculoskeletal
and neurological signs)[20]. The pain must be mechani-
cal in nature: i.e., there is no specific, identifiable etiol-
ogy but pain can be reproduced by movement or
provocation testing. Medications that could affect back
pain must be stable for the previous 30 days.
Exclusion Criteria
Participants are excluded if they have baseline pain
scores less than 3 on the 0-10 numerical rating scale,
inflammatory or destructive tissue changes of the spine,
surgical lumbar fusion or multiple lumbar surgeries, or
progressive neurological deficits.
Also exclusionary are ongoing LBP treatments by non-
study providers, current or pending litigation, pregnancy
or nursing, and certain medical conditions such as
blood clotting disorders or severe osteoporosis.
Contraindications to spinal manipulation results in
exclusion, as chiropractic care alone makes up the
monodisciplinary arm of the study. Subjects, however,
may have contraindications to a treatment modality in
the multidisciplinary treatment arm (e.g., have a needle
phobia) and still be included. In such instances there are
multiple other treatment modalities which can be used.
Eligibility Determination
Interested individuals contact study staff, who adminis-
ter a short questionnaire by phone to ascertain obvious
inclusion/exclusion criteria. Suitable candidates are
scheduled for a first baseline evaluation (BEV1), which
includes informed consent, a self-report questionnaire,
health history, physical examination, and x-rays if
indicated.
At completion of the BEV1, a standardized patient
profile is created which provides a comprehensive
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psycho-social perspective. Each profile includes clinical
and demographic characteristics: self-report of back pain
symptoms, disability, general health status, fear avoid-
ance and self-efficacy measures, and patient perspectives
(previous experience with LBP treatments, preferences
for care, and expectations of study treatments), as well
as physical exam and objective test findings.
The profile is reviewed by a multidisciplinary team of
chiropractic and allopathic physicians, radiologists, and
project managers during weekly case review meetings.
Case review occurs to facilitate consistent interpretation
and application of predefined eligibility criteria and is
held prior to randomization. Decisions regarding elig-
ibility are documented electronically. If eligible, potential
subjects are scheduled for a second baseline visit.
At the second baseline evaluation (BEV2), potential
participants undergo a review of informed consent, a
self-report questionnaire, and objective biomechanical
measures including lumbar dynamic motion and trunk
endurance. At the end of this visit, eligible and willing
participants are randomly assigned to one of two
interventions.
Randomization
Restricted randomization using a 1:1 allocation ratio has
been applied utilizing randomly permuted block sizes.
The randomization scheme and block sizes are con-
cealed to ensure blinding of the study team to treatment
assignments. As individuals become eligible, sequentially
numbered opaque envelopes are drawn to assign
treatment.
Treatment Overview
Patients receive 12 weeks of care in one of two treat-
ment arms: 1) monodisciplinary chiropractic care or 2)
multidisciplinary integrative care. Patients are requested
not to seek additional care for back pain during the
intervention phase; additional health care visits are cap-
tured on the self-report questionnaires. All activities
related to study treatment are documented using stan-
dardized electronic treatment records. Providers also
query the patient at each visit regarding additional
health care visits and side effects; these are documented
in the treatment record.
Patient Self Assessment Form
To assess their response to treatment during the inter-
vention phase, patients are asked to complete a Patient
S e l fA s s e s s m e n tF o r m( P S A F )a tt h ef i r s ta n ds u b s e -
quent visits. Patients choose a symptom and an activity
they identify as most affected by their LBP, rating each
on an 11-point scale (from “as good as it could be” to
“as bad as it could be”). The PSAF was modified from
the Measure Yourself Medical Outcome Profile
(MYMOP),[21] a valid, patient-generated measure used
to quantify treatment effects important to individual
patients. Individual responses are graphed over the
course of the intervention period.
Care Pathways
During the 12 weeks of active treatment, treating clini-
cians review patient progress by comparing the PSAF,
the self-rated symptom and activity, against benchmarks
of expected improvement based upon previous work by
study investigators. If prog r e s si sn o ts a t i s f a c t o r y ,a
patient’s profile may be returned to the clinical care
team for discussion and consideration of changing the
treatment plan within the protocols of the respective
treatment arm.
Guiding principles for treatment include minimizing
fear and catastrophizing, decreasing dependency, being
mindful of cost-effectiveness, consideration of patient
preferences, and avoiding arbitrary limits upon care.
Training
All clinicians underwent training prior to treating
patients in the study. Training included information on
the background and traditions of each healthcare disci-
pline, reviewing the available clinical evidence on the
effectiveness of each modality when used to treat low
back pain, applying an evidence-informed practice
model, and methods in coming to consensus as a team.
For the purpose of this study, an evidence-informed
practice model was defined as the combination of the
research evidence, clinical experience, and the prefer-
ences of the patient. Clinicians were also trained in all
the study protocols.
Monodisciplinary Chiropractic Care
The monodisciplinary chiropractic care team is made up
of three chiropractors who meet weekly to review the
profiles of newly randomized patients and to reach con-
sensus on possible treatment options. At the first visit, a
consultation is held between the treating chiropractor
and patient to establish and agree upon a 12-week care
plan.
The chiropractors must be experienced and licensed.
They are allowed to utilize any non-proprietary treat-
ment under their scope of practice not shown to be
ineffective or harmful. Typical visits last 15-30 minutes.
Therapies for which there is supporting evidence are
encouraged, including manual spinal manipulation (i.e.,
high velocity, low amplitude thrust techniques, with or
without the assistance of a drop table) and mobilization
(i.e., low velocity, low amplitude thrust techniques, with
or without the assistance of a flexion-distraction table).
Chiropractors may also use hot and cold packs, soft tis-
sue massage, teach and supervise exercise, and distribute
t h ee x e r c i s ea n ds e l f - c a r ee ducation materials used in
the multidisciplinary treatment arm (described below).
The number and frequency of treatment visits is
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response to care over time, guided by changes in the
self-selected symptom and activity rating on the PSAF.
Multidisciplinary Integrative Care
The multidisciplinary integrative care team is made up
of 2 chiropractors, 2 massage therapists, 2 traditional
Chinese medicine (TCM) practitioners, 2 psychologists,
an allopathic physician, and 2 exercise therapists. The
team works in a non-hierarchical fashion and all mem-
bers have an equal voice. Weekly meetings are held to
review profiles of newly randomized patients. Discus-
sions are held to develop one or more treatment plans
for each patient. Each treatment plan consists of one or
more modality represented by the multidisciplinary care
team and consensus must be reached among the care
team for the plan to be included in the subsequent care
consultation with the patient.
During the care consultation, the treatment plan
options and rationales developed by the team are pre-
sented. The patient then exerts a preference, selecting
one treatment plan, and begins 12 weeks of active treat-
ment. The number and frequency of treatment visits for
each modality is determined by the provider, guided by
changes in the patient’s self-selected symptom and activ-
ity rating on the PSAF.
The therapy modalities in the multidisciplinary treat-
ment arm can be delivered independently or in combi-
nation with one another.
Chiropractic As in the monodisciplinary treatment arm,
experienced, licensed chiropractors providing care in the
m u l t i d i s c i p l i n a r ya r mm a yu s ea n yn o n - p r o p r i e t a r y
treatment under their scope of practice not shown to be
ineffective or harmful. Typical visits last 15-30 minutes.
Therapies for which there is supporting evidence are
encouraged, including manual spinal manipulation (i.e.,
high velocity, low amplitude thrust techniques, with or
without the assistance of a drop table) and mobilization
(i.e., low velocity, low amplitude thrust techniques, with
or without the assistance of a flexion-distraction table)
[22,23].
Cognitive Behavioral Therapy Cognitive behavioral
therapy is provided by licensed psychologists. Sessions
last approximately 60 minutes. Treatment focuses on
the psychological and social influences affecting LBP
and attempts to modify the environmental and cognitive
processes contributing to the LBP experience. Because
no one technique has demonstrated more effectiveness
over another, a variety of operant and respondent cogni-
tive treatment approaches are used[24,25].
Exercise Exercise therapy is provided one-on-one by
exercise therapists under the supervision of licensed
clinicians. Typical sessions last 40-60 minutes.
Patients are shown exercises designed to enhance
mobility, coordination, and to increase trunk
endurance. These may include flexion/extension
motion cycles, hip/knee stretches, prone press ups
(back extension), squats, abdominal curl ups, side
bridge variations, and leg and arm extension varia-
tions[26]. Depending upon their ability and progress,
patients may attend a series of supervised exercise
therapy sessions or be provided with exercises to per-
form at home with in-person follow up. Written
materials with photos and simple instructions for the
exercises are given to the patient.
Massage therapy Therapeutic massage is provided by
nationally certified and locally licensed therapists. Ses-
sions last 60 minutes. Massage techniques considered
standard practice and not contraindicated in the litera-
ture are used[27]. These focus on manual contact for
the treatment of soft tissues (i.e., muscle and fascia) and
may include neuromuscular therapy, myofascial techni-
ques, trigger point therapy, and classic western style
Swedish massage.
Medication Medications are prescribed by a licensed,
board-certified medical doctor, with a typical appoint-
ment lasting 15-30 minutes. Therapies for which there
is supporting evidence and carrying minimal risk are
encouraged[28,29]. Choices are individualized, guided
by the patient’s health history, present medication use,
and the presence or absence of contraindications.
Medications may include non-steroidal anti-inflamma-
tory drugs (NSAIDS), analgesics, and/or muscle
relaxants.
Self-care education Self-care education is provided by
exercise therapists under the supervision of licensed
clinicians. Typical sessions last 40-60 minutes. Patients
are taught spine posture awareness for activities of daily
living specific to their abilities, such as lifting, pushing
a n dp u l l i n g ,s i t t i n ga n dg etting out of bed[30,31].
Patients also receive a booklet[32] that encourages
movement, the use of ice or heat when needed, and
restoration of normal activities.
Traditional Chinese Medicine (TCM) Traditional Chi-
nese Medicine, including acupuncture, is provided by
experienced, licensed providers who are National Cer-
tification Commission for Acupuncture and Oriental
Medicine (NCCAOM) and Clean Needle Technique
(CNT) certified. Typical appointments last 45-60 min-
utes. Clinicians may use any treatment under their
scope of practice not shown to be ineffectual or cause
harm with the exception of herbs (excluded due to the
difficulty in guaranteeing quality) and moxabustion
(excluded due to a lack of ventilation in the treatment
rooms). Therapies for which there is supporting evi-
dence and carrying minimal risks are encouraged
[33,34]. Acupuncture, liquid moxa with a heat lamp,
Tui Na (Asian bodywork), and cupping are all
permitted.
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Outcomes are measured by patient self-report, blinded
objective assessment, and in-person and telephone inter-
views. Data are collected at baseline, during the 12-week
treatment period, and over the course of one year fol-
lowing randomization. Participant flow, study visits, and
evaluations are shown in Figure 1.
Self-report outcome measures
Patient-rated pain is the primary outcome measure.
Patients are asked to rate their typical LBP over the last
week on an ordinal 11-box scale (0 = no LBP, 10 = the
worst LBP possible)[35].
Secondary outcome measures include frequency of
symptoms, low back disability, fear avoidance, self-effi-
cacy, general health status, improvement, satisfaction,
work loss, and medication use.
Frequency of symptoms is rated for 1) back pain, 2)
leg pain, 3) numbness or tingling in the leg, foot or
groin, and 4) weakness in leg or foot on a 0 to 6 scale
(0 = not at all, 6 = always)[36,37].
Low back disability is measured with the Modified
Roland Scale, a 23-item questionnaire that assesses the
degree to which LBP restricts daily activities[36,38].
Fear avoidance is evaluated with the Fear-Avoidance
Beliefs Questionnaire, consisting of 21 items that quan-
tify fear-avoidance beliefs about work and physical activ-
ity. Each item is a statement; the patient is asked to rate
their degree of agreement/disagreement on a 0 to 6
scale (0 = completely disagree, 6 = completely agree)
[39].
Self-efficacy is measured by the Pain Self-Efficacy
Questionnaire, a 10-item scale used to assess the level
of self-confidence in performing functional and social
Review Patient Profile 
Develop Individual Treatment Plan 
Phone Screen 
Baseline Evaluation 1 (BEV1) 
Baseline Evaluation 2 (BEV2)
Informed Consent 2 
Questionnaire 
Randomization 
Informed Consent 1 
Questionnaire 
Physical Exam 
Objective Assessment  Case Review 
Chiropractic Care 
N=100 
Integrative Care 
N=100
Week 4 Evaluation 
Week 12 Evaluation 
Months 6 & 12 Evaluation
Questionnaire 
Questionnaire 
Objective Assessment 
Qualitative Interview 
Mailed Questionnaire 
Months 4-12 Evaluation Phone Interviews 
 12 Week Intervention Period
Chiropractic Team Review  Integrative Team Review 
Treatment Plan Consultation
Figure 1 Participant Flow, Study Visits and Evaluations. Questionnaires: patient-rated outcomes, expectations, preferences, cost and utility
measures. Objective Assessment includes blinded testing of motion and endurance. Phone Interviews include cost-measures. Qualitative
Interviews include questions regarding perceptions of treatment, determinants of satisfaction.
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between 0 (no self-efficacy) and 60 (highest self-efficacy)
[40].
General health status is assessed by the EuroQol 5D,
a multi-attribute utility scale (MAUS) covering five
dimensions (mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression) with three levels
(no problem, moderate problem, severe problem)
[41,42].
Improvement is measured by asking patients to com-
pare their LBP condition to what it was before treat-
ment using a 9-point ordinal scale. Response choices
range from no symptoms (100% improvement) to twice
as bad (100% worse)[43].
Satisfaction is assessed using seven questions addres-
sing different aspects of patient care with 5 response
choices (1 = poor, 5 = excellent)[32,44]. Overall satisfac-
tion with care is also measured on a 7-point ordinal
scale (1 = completely satisfied, 7 = completely
dissatisfied).
Work Loss is assessed by three questions based on
items from the National Health Interview Survey
(NHIS)[45]. Each question asks the patient to reflect
back over a specified time period and report the number
of days they missed work or school, spent in bed, and
cut down on usual activities for more than half a day
due to back pain.
Medication Use, including non-prescription and pre-
scription medication, is measured using a 5-point scale.
Patients indicate how frequently they have taken medi-
cation for their LBP in the past week (1 = have not
taken any, 5 = taken daily)[44,46].
Objective outcome measures
Secondary objective outcomes, lumbar dynamic motion
and torso muscle endurance, are measured by examiners
blinded to treatment assignment at baseline and week
12 (post-intervention).
Lumbar dynamic motion is assessed using the Zebris
CMS-HS Spine Motion Analyzer (Zebris Inc., Isny im
Allgau, Germany)[47,48]. The system acquires 3-dimen-
sional motion data through measurement of ultrasonic
pulses traveling between ultrasound emitter arrays
applied to the patient and a stable microphone. Patients
are asked to perform flexion-extension, rotation, side-
bending, and circumduction motion.
Torso muscle endurance of the trunk flexors, lateral
flexors, and extensors is measured using procedures
described by McGill[49]. These tests have been shown
to be valid and reliable measures of torso muscle endur-
ance[50,51]. Test data consists of the time (in seconds)
that each posture is held. Strength of the trunk flexor
and extensor musculature is measured by assessing peak
effort in pounds.
Qualitative measures
Qualitative interviews are conducted with patients indivi-
dually at the end of the 12-week treatment period[52]. A
schedule of questions is used to direct the interviews and
keep them on a path consistent with the purpose of the
study[53]. The format is semi-structured, with open-ended
questions followed by probing questions, if indicated.
Patients are asked how they felt about the treatment they
received, whether it met their expectations, and what they
liked and disliked about treatment. They are also asked to
identify factors considered when determining their satis-
faction with care. Providers are interviewed when the
study is completed. These interviews explore the clinicians’
experiences working with other providers in their respec-
tive mono- and multidisciplinary clinical care teams, as
well as the perceived usefulness of the care pathways.
Permission is sought to audio-record the interviews,
and patients are assured confidentiality, allowing them
to speak freely in response to the questions[52]. All
interviews are transcribed for analyses. To ensure con-
sistency over the course of the study, audio-taped inter-
views are monitored for standardized interview
techniques and 10% of interview transcripts are ran-
domly sampled and compared to recorded interviews for
accuracy.
Cost-Effectiveness and Utility Measures
A societal perspective will be taken as the basis for the
cost-effectiveness measurement and analyses. Thus,
direct health care costs, direct non-health care costs,
and indirect costs will be used as the economic indica-
tors[54,55]. These cost measures are collected from
standardized study provider forms at each study treat-
ment visit and patient self-report questionnaires at
months 4, 12, 26, and 52. Telephone interviews occur
monthly from weeks 12 to 52.
Direct costs for each patient will represent the pain-
or disease-related medical costs based on utilization and
estimated costs. This will include the costs of the study
treatments to which patients are randomized and costs
for additional visits to non-study health care providers,
prescription medications, advanced imaging (CT, MRI),
and hospitalization. Direct non-health care costs will
include out-of-pocket expenses (non-prescription medi-
cations), informal care, and travel expenses.
Indirect costs will include loss of productivity due to
back-related absence from work or days of inactivity.
Days in which activity is restricted due to LBP are
assessed by three questions based on items from the
National Health Interview Survey (NHIS)[45].
Cost utility will be measured using the EuroQol 5D,
which has been valued by a large sample of the general
population using time trade-off evaluations. It is a brief,
easily completed instrument and is considered to be one
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able[41,56].
Other Measures
Patient expectations are evaluated based on questions
used in previous studies by the investigators. Prior to
randomization (at BL2), patients are asked to rate how
helpful they believe each treatment to be on an 11-box
scale (0 = not at all helpful, 10 = extremely helpful)[57].
Patients are asked to report side-effects in the patient
self-report questionnaires by choosing from a list of
side-effects generated from previous studies by the
investigators assessing chiropractic care and exercise
[58,59]. For each side-effect chosen, the patient is asked
to rate the bothersomeness of the side-effect on an 11-
box scale (0 = not at all bothersome, 10 = extremely
bothersome). This method of recording side-effects is an
attempt to standardize side-effect reporting in clinical
trials, which has been inadequately addressed in much
of the research performed to date[9].
Data Analysis
Treatment Effectiveness
Power was calculated to detect an 8 to 9 percentage
point difference between groups in the primary outcome
measure of patient self-reported pain after 12 weeks and
one year. A sample size of 100 patients per group pro-
vides 80% power assuming an alpha level of .05. This
allows for a 15% loss to follow up.
Mixed-Model analysis of covariance (ANCOVA) will
be used to test for differences between groups in
patient-rated primary and secondary outcomes in both
the short- (12 weeks) and long-term (52 weeks). Base-
line values will be used as covariates when appropriate;
intention-to-treat analysis will be used[60]. A sensitivity
analysis will be performed, including patient expecta-
t i o n sa sac o v a r i a t et oa s s e s si t si n f l u e n c eo ns t u d y
results.
Cost-effectiveness Analysis
A cost comparison of the intervention groups using data
on direct and indirect costs will be conducted. Cost dif-
ferences between groups will be estimated for all costs
up to weeks 12, 26, and 52. ANCOVA will be used as in
the primary analysis to yield the mean difference
between groups, adjusted for baseline costs and other
important baseline covariates that are identified.
A cost-effectiveness analysis (CEA) comparing the two
intervention groups using pain as the effectiveness mea-
sure will also be performed. Cost-effectiveness will be
evaluated with the incremental cost-effectiveness ratio
(ICER). The ICER is defined for this study as the
adjusted mean difference between groups in costs
divided by the adjusted mean difference in patient-rated
pain. ICER will be calculated at the same time points
used in the primary analysis.
A cost-utility analysis (CUA) will be performed to
compare the intervention and control groups using the
EuroQol-5D. Utility will replace pain in the ICER.
Qualitative Analysis
Content analysis using an inductive approach[61] will be
used to identify categories and themes that occur in the
transcribed text generated from the qualitative inter-
views[62]. Transcribed data will be entered into a data-
base (ATLAS.ti) designed to capture and analyze
qualitative data.
The text of ten interviews will be read independently
by two investigators to gain an overall impression and
to establish and define preliminary codes in response to
the proposed questions[63,64]. After the initial analysis,
the investigators will meet to reach a consensus on pre-
liminary codes. These codes will be entered into a “code
book,” which will provide a detailed definition for each
code[62]. Information related to methodological deci-
sions and their rationale will also be documented[61].
Subsequent transcripts will be independently reviewed
to identify and code text segments and to assess the
inter-rater reliability of text coding. Kappa values of less
than 0.8 will necessitate review of the coding structure.
Investigators will meet after each set of twenty inter-
views to revise the code book and add new codes as
necessary, grouping them into thematic categories. The
frequency of themes will be quantified and representa-
tive quotations will be identified[62,65]. The investiga-
tors will independently review the summarized
information and verify it for consistency with the origi-
nal text. Categorized information from the transcribed
interviews will be entered in matrices to organize and
display categories by treatment groups as a means of
illustrating relationships among categories[66]. This
information will then be summarized and interpreted.
Findings will be discussed until consensus is reached.
The frequency of themes will be quantified and repre-
sentative quotations will be identified[62,65]. The fre-
quency of responses in the thematic categories will
be cross-tabulated with treatment group assignment
and compared for between-group differences using
Chi-square analysis. 95% confidence intervals will be
calculated for these differences.
Discussion
The design of this randomized clinical trial (RCT), with
cost-effectiveness and qualitative studies conducted
alongside the RCT is innovative in several ways.
First, it uses flexible clinical care pathways, which
allow for provider and patient choice within the context
of study protocols. The ability of the clinician to assess
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real-world care, while also valuing the provider’sc l i n i c a l
experience. It also forces, in the multidisciplinary treat-
ment arm, discussion across disciplines; when patients
don’t meet benchmarks, their case is returned to the
care team for review and possibly a change in treatment
plan. It has been suggested that combining modalities
could have a synergistic effect that might lead to greater
improvements;[67] this trial encourages the combination
of CAM and conventional treatment. Finally, allowing
patients to express their treatment plan preference may
increase positive treatment effects. Although this study
cannot examine preference alone, patients’ qualitative
experiences will be captured, which can lead to greater
understanding of how preference may influence treat-
ment outcomes.
Second, the multidisciplinary intervention is a non-
hierarchical model where consensus is reached among
the conventional medicine and CAM team members
when formulating treatment plans. The advanced level
of integration of the multidisciplinary team, where dis-
parate practitioners reach decisions and consensus as a
group, will inform future endeavors by modeling one
possible method of practice.
Finally, this study applies t h eb e s ta v a i l a b l ee v i d e n c e
for both conventional medicine and CAM to meet the
needs of individual LBP patients. Individualizing care
has the potential to maximize outcomes in non-specific
low back pain when multiple efficacious treatments by
themselves have modest effects when applied to the
group overall. This study may add to our understanding
of the biopsychosocial model of low back pain and
whether it could be translated into a useful profile of
each patient to guide care.
The study is anticipated to be completed in 2010, at
which time results will be made available.
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